Quantcast

Posts Tagged ‘New York Times’

October 15th, 2009

Dr. Richard Podell: Chronic Fatigue Syndrome, or the Yuppie Flu, Is Legit

diane

 

Dr. Richard Podell

Dr. Richard Podell

Tell a friend you’re suffering from Chronic Fatigue Syndrome (CFS) and they’ll cluck in sympathy. But a mind reader would hear “Huh? What a hypochondriac!”

CFS is often dismissed as the “yuppie flu” and thought of as a mental not physical ailment.  Patients are often labeled as neurotic or depressed. Those who suffer from the ailment find the word “syndrome” offensive, which implies that it is not a real disease.

Not so. According to the cover of the New York Times Science Section, a study published last week in the Journal of Science reports that many patients who have the syndrome are infected with a recently discovered virus. The link has intrigued scientists and is seen as vindication by some patients and inspired hope for a treatment.

Dr. Richard Podell, a well-known Chronic Fatigue Syndrome specialist describes CFS as a condition in which mild physical or mental exertion induces severe fatigue and increased activity will typically cause symptoms to worsen.

According to Vitals.com, Podell received his medical degree at Harvard University and completed a specialty residency at Mt. Sinai Medical Center.

CFS has long been a medical mystery and the subject of debate, sometimes bitter, among doctors, researchers and patients. This syndrome affects at least one million Americans, causing extreme fatigue, muscle and joint pain as well as sleep problems, difficulty concentrating and other symptoms that sometimes last for years. Its cause is unknown and there is no effective treatment.

Annette and Harvey Whittemore long believed Chronic Fatigue Syndrome was an infectious disease, but scientists rejected the idea. The Whittemores were extremely frustrated with the lack of progress in the scientific community, especially since their 31 year old daughter suffered from this syndrome for over twenty years. They decided if a place was created to find the answers a treatment would be found more quickly.  In 2004 they spent several million dollars to set up an institute at the University of Nevada, hiring Dr. Judy Mikovits to head the research. Indeed a test is expected to become available within two weeks, which is one step closer to finding treatment.

What Mikovits and researchers from the National Cancer Institute and the Cleveland Clinic discovered was a strong link between Xenotropicmurine, or XMRV, and CFS. But although they established a link, it still hasn’t been proven whether or not XMRV is the actual cause of CFS.

XMRV is a retrovirus that’s from the same notorious family that causes AIDS and leukemia in people. It was first identified three years ago in a case of prostate cancer and later detected in about one quarter of biopsies from men with that disease.

Mikovits reported in Science that they’d found that 68 of 101 patients with chronic fatigue or 67% were infected with XMRV compared with only 3.7% of 218 healthy control patients. Further testing after the paper was written found nearly 98% of about 300 patients had the syndrome. Mikovits believes that the virus will eventually be found in every patient with chronic fatigue syndrome.

Their next step will be working out whether XMRV causes CFS or just grows particularly well in people who have it. If XMRV does turn out to contribute to CFS this could point to new treatments. 

Medical skeptics believe the study is exciting but inconclusive. They feel that more work needs be done to find out whether the new virus plays a role in CFS. Just detecting it in a patient doesn’t prove they suffered from a syndrome whose very existence they questioned

But doctors who specialize in CFS adamantly disagree and are frustrated that medical science still hasn’t caught up with this debilitating disease. This new discovery may have finally turned things around for this poorly understood illness that affects more than a million Americans.

[del.icio.us] [Digg] [Facebook] [Google] [LinkedIn] [Mixx] [MySpace] [Sphere] [StumbleUpon] [Technorati] [Twitter] [Windows Live] [Yahoo!] [Email]
VN:F [1.7.4_987]
Rating: 9.5/10 (6 votes cast)
VN:F [1.7.4_987]
Rating: +1 (from 1 vote)

4 Comments » Post a Comment »

October 13th, 2009

Dr. Thomas Kosten – A Vaccine That Prevents Cocaine Highs

diane
Dr. Thomas Kosten

Dr. Thomas Kosten

What happens when a cocaine addict takes a snort of cocaine and doesn’t get high? A new experimental vaccine accomplishes just that, creating antibodies that deactivate the drug before it enters the brain and preventing users from feeling anything. The hope is that if addicts don’t get high they will stop taking the drug. Or will it cause them to increase their intake to try to overcome the effects? Time will tell.

Dr. Thomas Kosten, professor at Baylor College who worked on this research at Yale, found that the vaccine created enough of a response in some subjects allowing them to cut their drug use by half.

“This is the first study that has ever been done with an illicit drug to show that a vaccine can be effective in humans,” said Kosten.

According to Vitals.com, Kosten received his medical degree at Cornell University and completed his residency in psychiatry at Yale.

(psychcentral.com)

(psychcentral.com)

The New York Times reports that the clinical trial consisted of 115 addicts who attended a methadone clinic but also used cocaine and other drugs. 58 participants were given the vaccine, while 57 were given dummy injections. Although 55 of the participants received all the shots, only 21 or 38 percent developed enough antibodies to block the effect of cocaine on their brains.

Those who reached the threshold had significantly more cocaine free urine samples than the others, with 53 percent reducing their cocaine use by half, compared with the 23 percent that were vaccinated but did not make sufficient antibodies. Although the effect wore off after only two months.

“That was pretty impressive because they were daily users of cocaine and in effect they mostly stopped using cocaine, though they tested it every couple of weeks to see ‘Gee, can I get high now.’ ” Kosten asserts.

He feels that though the drug doesn’t prevent the craving, with the help of antibodies it can prevent relapses for those who want to quit.

“Antibodies are very large proteins and when the cocaine attaches to those antibodies it can’t get into the brain or heart so drug users feel nothing,” said Kosten.

Dr. Kosten feels that such vaccines would be suitable for all kinds of addictive substances except alcohol.

“This raises the chances of tackling addictions to smoking, heroin and methamphetamines.”

READ MORE ABOUT DR. THOMAS KOSTEN

[del.icio.us] [Digg] [Facebook] [Google] [LinkedIn] [Mixx] [MySpace] [Sphere] [StumbleUpon] [Technorati] [Twitter] [Windows Live] [Yahoo!] [Email]
VN:F [1.7.4_987]
Rating: 0.0/10 (0 votes cast)
VN:F [1.7.4_987]
Rating: 0 (from 0 votes)

2 Comments » Post a Comment »

August 6th, 2009

Dr. Joseph Ross on Pharmaceutical Companies Manipulating Medical Literature to Boost Sales

diane
Dr. Joseph Ross

Dr. Joseph Ross

How much of medical literature is influenced by the drug industry? A front page article in Wednesday’s New York Times reports that ghostwriters were hired by a pharmaceutical company to help produce 26 scientific papers stressing the benefits and downplaying the risk of hormone replacement therapy in women.

“It’s almost like steroids and baseball,” said Dr. Joseph S. Ross, an assistant professor of geriatrics at Mount Sinai School of Medicine who conducted the  research on ghostwriting. “You don’t know who was using and who wasn’t; you don’t know which articles are tainted and which aren’t.”

According to Vitals.com, Dr. Ross received his medical degree at Albert Einstein College of Medicine and completed his training in internal medicine at Montefiore Medical Center.

Prempro Sales Drop Due to Deadly Side Effects (Nytimes.com)

Prempro sales drop due to fatal side effects (nytimes.com)

Court documents have disclosed that Wyeth, a major drug company, paid a medical communications firm to outline these articles while withholding their role and identity. A paper trail was left following each step, from hiring writers to soliciting physicians who signed their names whether or not they contributed anything. The court papers also revealed that this practice was not limited to Wyeth, but also used by other drug companies.

At one time the Premarin family of drugs, medication used for hormone therapy, was one of Wyeth’s bestsellers. These articles assisted in boosting sales to nearly 2 billion in 2001, especially since most doctors rely on this literature to help them decide whether or not to change their prescription habits.

The drug’s popularity was compromised when researchers found that menopausal women who took certain hormones had an increased risk of invasive breast cancer, heart disease and stroke. An even later study showed the medication raised the threat of dementia in older patients.

Some medical journals are now more conscious of the ghostwriter’s potential influence. They have required authorship forms that oblige writers to detail their role in an article and list any conflicts of interest.

Wyeth faces about 8,400 lawsuits which accuse them of selling a drug that caused women to develop illnesses, the unfortunate casualties of competitive big business.

READ MORE ABOUT DR. JOSEPH ROSS

[del.icio.us] [Digg] [Facebook] [Google] [LinkedIn] [Mixx] [MySpace] [Sphere] [StumbleUpon] [Technorati] [Twitter] [Windows Live] [Yahoo!] [Email]
VN:F [1.7.4_987]
Rating: 0.0/10 (0 votes cast)
VN:F [1.7.4_987]
Rating: 0 (from 0 votes)

3 Comments » Post a Comment »


-->